https://www.youtube.com/watch?v=iqJeIAUjyxg
Prof. Fabien Zoulim - INSERM - IP-cure-B Project

https://www.aphc.info/speakers/zoulim-fabien/
Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. He has been the scientific coordinator of a European Community-funded Network of Excellence on the management of antiviral drug resistance. He is currently coordinating the ANRS "HBV cure" program in France and the IP-cure-B project within the

https://aphc-paris.com/committees/faculty/m-fabien-zoulim
Fabien ZOULIM is Professor of Medicine at Lyon I University since 1997. He is Head of the Hepatology Department at the Hospices Civils de Lyon, and Head of the Viral Hepatitis Research Laboratory of INSERM Unit 1052. ... and the "IP-cure-B" project funded by the EU H2020 workprogram. He co-founded the International Coalition to Eliminate

https://ice-hbv.org/?board=fabien-zoulim
Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. He is currently coordinating the ANRS "HBV cure" Task Force in France and the "IP-cure-B" project within the EU H2020 workprogram. He co-founded the International Coalition to Eliminate HBV (ICE-HBV: http//:www.ice-hbv.org). He has

https://www.globalhep.org/dr-fabien-zoulim
He is Professor of Medicine at Lyon I University since 1997. He is Head of the Hepatology Department at the Hospices Civils de Lyon, and Head of the Viral Hepatitis Research Laboratory of INSERM Unit 1052. He founded the Lyon Hepatology Institute in 2023. Dr Zoulim is currently Associate Editor for Gut. He also served as a Governing Board

https://primeinc.org/faculty-biography/fabien-zoulim-md-phd-3262
Fabien Zoulim, MD, PhD. Professor of Medicine Medical Director, Hepatology Department Université Hospital of Lyon Scientific Director, Viral Hepatitis Research Laboratory ... He is currently coordinating the ANRS HBV Cure Task Force in France and the "IP-cure-B" project within the EU H2020 program. He co-founded the International Coalition to

https://ice-hbv.org/take-home-message-from-the-9th-anrseid-hbv-cure-conference-interview-with-fabien-zoulim/
On the occasion of World Hepatitis Day on July 28 th 2022, Fabien Zoulim, professor of medicine in Lyon, coordinator of the European project "IP-cure-B", the RHU project "CirB-RNA", the ANRS Task Force "HBV Cure" and current chair of ICE-HBV presents the take home messages from the 9 th HBV cure workshop held in Lyon on July 5 th, 2022.

https://www.journal-of-hepatology.eu/article/S0168-8278(23)00029-6/pdf
E-mail address: fabien.zoulim@inserm.fr (F. Zoulim). Received 11 January 2023; accepted 16 January 2023; available online 27 January 2023 ... 847939-IP-cure-B). Conflict of interest FZ received consulting fees from Aicuris, Aligos, Antios, Assembly, Blue Jay, Evotec, Gilead, GSK, Zhimeng. FZ and BT received research grants from As-

https://www.journal-of-hepatology.eu/article/S0168-8278(17)32480-7/pdf
Inhibition of hepatitis B virus gene expression: A step towards functional cure. Fabien Zoulim⇑. Hepatology Department, Hospices Civils de Lyon, Lyon University, INSERM U1052 -Cancer Research Center of Lyon (CRCL), 151 Cours Albert Thomas, 69003 Lyon, France See Article, pages 412-420 Despite the availability of a preventive vaccine and

https://theorg.com/org/assembly-biosciences/org-chart/fabien-zoulim
He is currently coordinating the ANRS "HBV cure" program in France and the "IP-cure-B" project within the EU H2020 workprogram and co-founded the International Coalition to Eliminate HBV. Dr. Zoulim is a recognized expert in the field of viral hepatitis and antiviral therapy and has published more than 400 articles.

https://www.aphc.info/wp-content/uploads/2020/02/6-pre40-zoulim-fabien.pdf
Fabien Zoulim Hepatology Department, Hospices Civils de Lyon INSERM U1052, Cancer Research Center of Lyon Lyon University, France. Goals of future therapies to cure HBV infections Therapy H B V D N A c h a n g e f r o m b a s e l i n e (l o g 1 0 c / m L) 0.0-1.0-2.0-3.0-4.0 +1.0 Time HBsAg HBV DNA cccDNA SERUM LIVER

https://www.cirb-rna.fr/media/take-home.pdf
development. On the occasion of World Hepatitis Day on July 28th 2022, Fabien Zoulim, professor of medicine in Lyon, coordinator of the European project "IP-cure-B", the RHU project "CirB-RNA", the ANRS Task Force "HBV Cure" and current chair of ICE-HBV presents the take home messages from the 9th HBV cure workshop held in Lyon on July 5th, 2022.

https://academicmedicaleducation.com/fabien-zoulim-md-phd
Fabien Zoulim obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He is Professor of Medicine at Lyon I University since 1997. He is Head of the Hepatology

https://www.thelancet.com/pdfs/journals/langas/PIIS2468-1253(19)30119-0.pdf
A global scientific strategy to cure hepatitis B Peter A Revill, Francis V Chisari, Joan M Block, Maura Dandri, Adam J Gehring, Haitao Guo, Jianming Hu, Anna Kramvis, Pietro Lampertico, ... Prof Fabien Zoulim, INSERM U1052 - CRCL , 151 Cours Albert Thomas, 69003 Lyon, France fabien.zoulim@inserm.fr See Online for appendix HBsAg, pre-S truncation

https://www.aphc.info/materials-phc-paris-hepatology-conference-2017/novel-targets-hepatitis-b-virus-therapy/
Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. He has been the scientific coordinator of a European Community-funded Network of Excellence on the management of antiviral drug resistance. He is currently coordinating the ANRS "HBV cure" program in France and the IP-cure-B project within the

https://perspectivesinmedicine.cshlp.org/content/5/4/a021501.full.pdf
Figure1. Schematic of interferon (IFN)-a and nucleoside analog (NA) modes of action. NAs block the synthesis of relaxed circular DNA (rcDNA) into neosynthesized nucleocapsids by acting as chain terminator for hepatitis B virus (HBV) polymerase. IFN-a has both direct and indirect actions on HBVreplication in vivo.

https://hstalks.com/expert/1979/prof-fabien-zoulim/
Prof. Fabien Zoulim Lyon University and INSERM, France ... Fabien Zoulim obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. ... The path towards a cure for

https://uat.ice-hbv.org/?board=fabien-zoulim
He also served as a Governing Board member of the European Association for the Study of the Liver (EASL). Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. He is currently coordinating the ANRS "HBV cure" Task Force in France and the "IP-cure-B" project within the EU H2020 workprogram.

https://typeset.io/papers/therapeutic-strategies-for-hepatitis-b-virus-infection-1xl1xxfvaw
(DOI: 10.1038/S41573-019-0037-0) Chronic hepatitis B virus (HBV) infection is a common cause of liver disease globally, with a disproportionately high burden in South-East Asia. Vaccines and nucleoside or nucleotide drugs are available and reduce both new infection rates and the development of liver disease in HBV-positive persons who adhere to long-term suppressive treatment. Although there

https://inserm.hal.science/inserm-00560092/file/Zoulimfinal2.pdf
Fabien Zoulim (1,2,3) 1) INSERM, U871, 69003 Lyon, France ; 2) Université de Lyon, 69003 Lyon, ... Prof. Fabien Zoulim INSERM Unit 871 151 Cours Albert Thomas, 69003, Lyon, France e.mail: fabien.zoulim@inserm.fr Word count Abstract : 241 Manuscript: 2 Abstract Chronic HBV infections remain a major public health problem worldwide. According to WHO

https://www.aphc.info/phc-paris-hepatology-conference-2018-materials/improve-access-therapy-hepatitis-b-patients/
Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. He has been the scientific coordinator of a European Community-funded Network of Excellence on the management of antiviral drug resistance. He is currently coordinating the ANRS "HBV cure" program in France and the IP-cure-B project within the

https://www.natap.org/2014/HBV/010515_01.htm
This AC is composed of a scientific committee composed of 35 members with as president Professor Fabien Zoulim (Inserm U1052, Cancer Research Center of Lyon). They will identify new therapeutic targets (virological and immunological targets) in order to prevent the complications of infection with hepatitis B improved antiviral treatments with

https://ice-hbv.org/wp-content/uploads/2020/12/Position-at-Inserm-Unit-1052-Lyon.pdf
UMR INSERM 1052-CNRS 5286-UCBLCLB INSERM U1052, 151 Cours Albert Thomas, 69003 Lyon, ... coordinated by Prof Fabien Zoulim • Link with the HIV, IST and viral hepatitis clinical research department of the ANRS ... Administrative coordination of the H2020 collaborative research project "IP-cure-B